GC Therapeutics claims it can create off-the-shelf therapies from induced pluripotent stem cells faster and simpler than current methods.

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.